NBTC Approval for Wireless Medical Devices in Thailand

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Medical devices containing wireless technologies such as Bluetooth, Wi-Fi, cellular networks or RFID need a second approval to enter Thailand: beyond the Thai FDA registration, they must obtain approval from the NBTC, the National Broadcasting and Telecommunications Commission. This is a separate approval process from the Thai FDA, and it must be completed before import. The review takes approximately 30 to 45 working days, and the official fee is approximately 200 US dollars, figures that reflect industry experience and are subject to the NBTC current publication, pending verification against the announcement in force at the time. In most cases the NBTC accepts equivalence recognition of FCC or CE test reports, which means products already holding US or EU wireless certification usually do not need to redo radio testing, but the equivalence recognition must be confirmed case by case and cannot be assumed.

  • The NBTC approval is independent of the Thai FDA process but can proceed in parallel with the Thai FDA registration.
  • The approval must be completed before import.
  • The review takes approximately 30 to 45 working days, and the official fee is approximately 200 US dollars, an industry experience value pending verification against the current NBTC publication.
  • In most cases the NBTC accepts equivalence recognition of FCC or CE test reports, so products with existing US or EU wireless certification usually avoid redoing radio testing; the recognition must be confirmed case by case.
  • Wireless devices are regulated wireless equipment; importing without NBTC approval causes the goods to be blocked at the customs clearance stage and may trigger the corresponding penalties.
  • Because NBTC approval must precede import, discovering the gap only when the goods reach port produces port detention costs.

2. Legal basis

The obligation rests with the NBTC, the National Broadcasting and Telecommunications Commission, which approves wireless equipment independently of the medical device regulator. Wireless devices fall under regulated wireless equipment, and importing them without NBTC approval obstructs customs clearance and may trigger penalties. The import-stage requirements for commercial purposes are published on the Thai FDA website under the For Commercial Purpose section of the import process. The review period of approximately 30 to 45 working days and the official fee of approximately 200 US dollars are industry experience values, pending verification against the figures currently published by the NBTC. The acceptance of FCC or CE test reports through equivalence recognition holds in most cases but must be confirmed case by case rather than defaulted. Because the approval is independent of the Thai FDA review, the two processes can be run in parallel, and the sequencing guidance is to start both at the same time: the Thai FDA review focuses on safety and effectiveness while the NBTC review focuses on radio spectrum and equipment compliance, and since the NBTC needs only 30 to 45 working days it usually finishes ahead of the Thai FDA.

3. Expert insights

The expensive failure mode in this area is not a rejection but a surprise. Wireless functionality in medical devices is frequently hidden in plain sight: a device with built-in Wi-Fi used for data upload, or consumables carrying RFID tags for identification, are wireless products even when nobody on the project described them that way. Teams that omit the wireless screening question from the project start checklist discover the NBTC requirement when the goods reach port and cannot clear customs, which is the classic pattern of a low-cost, avoidable risk surfacing as a high-cost, unavoidable event, complete with port detention costs and a delayed launch. The correct posture has three parts. First, screen every product for wireless modules at project start and treat a positive answer as a second approval track to be planned, not as a footnote. Second, run the NBTC process in parallel with the Thai FDA registration rather than in series; the reviews do not depend on each other, and serial execution adds one to two months of pure waiting. Third, use the equivalence recognition of FCC or CE test reports wherever it can be confirmed case by case, because skipping a redundant radio test round is the main lever for compressing the NBTC timeline.

4. Practical recommendations

  • Add a wireless module screening item to the project start checklist, and examine the product design rather than the marketing description, since Wi-Fi for data upload and RFID for identification are easy to overlook.
  • Start the NBTC approval and the Thai FDA registration at the same time and run them in parallel; do not serialise them, because serial execution adds one to two months for no benefit.
  • Plan for the NBTC review duration of approximately 30 to 45 working days and the official fee of approximately 200 US dollars, treating both as industry experience values pending verification against the current NBTC publication.
  • Where FCC or CE test reports exist, apply for equivalence recognition and confirm it case by case before relying on it to avoid redoing radio testing.
  • Confirm that NBTC approval is granted before import is scheduled, so the shipment never reaches port without the approval in hand and no detention costs arise.
  • Consult the For Commercial Purpose section of the import process on the Thai FDA website for the import-stage requirements that apply to the shipment.

5. Verification checklist

  • □ Verification basis date: 26 October 2026.
  • □ NBTC, the National Broadcasting and Telecommunications Commission, approval requirements for wireless devices.
  • □ Review period of 30 to 45 working days and official fee of approximately 200 US dollars, industry experience values pending verification against the current NBTC publication.
  • □ Completion of the approval before import.
  • □ Equivalence recognition of FCC or CE test reports accepted in most cases, to be confirmed case by case.
  • □ Parallel processing with the Thai FDA registration.
  • □ For Commercial Purpose import-stage requirements on the Thai FDA website.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across Southeast Asia, including Thailand. Our team prepares dossiers to ASEAN CSDT structure, manages submissions and deficiency responses with the Thai FDA, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail